| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 01/17/2001 | EP1067920A1 Methods and compositions for reducing uv-induced inhibition of collagen synthesis in human skin |
| 01/17/2001 | EP1067896A4 Ascorbyl-phosphoryl-cholesterol |
| 01/17/2001 | EP1067896A1 Ascorbyl-phosphoryl-cholesterol |
| 01/17/2001 | EP0983258A4 N-hydroxy 4-sulfonyl butanamide compounds |
| 01/17/2001 | EP0771216B1 Methods and compositions for the specific coagulation of tumoral vasculature |
| 01/17/2001 | EP0614354B1 Use of salicylic acid for regulating skin atrophy |
| 01/17/2001 | CN1280613A Isolated nucleic acid molecule encoding mammalian endoglucuronidase and uses therefor |
| 01/17/2001 | CN1280572A Inhibiting platelet derivative growth factor and/or quinoline and quinowoline compounds of P56lek tyrosinkinase |
| 01/17/2001 | CN1280009A Enopeptin containing compound preparation and its medical use for controlling sutaneous pigmentation |
| 01/17/2001 | CN1280002A Ointment for curing skin ulcer |
| 01/17/2001 | CN1279983A Ointment for cruing skin trauma and its preparing method |
| 01/17/2001 | CN1279974A Compound red and yellow psoriasis capsule |
| 01/17/2001 | CN1279967A Chinese herbal medicine preparation for curing keloid |
| 01/17/2001 | CN1279957A Use of puffer liver oil in preparing food for curing poisonous drug dependence |
| 01/17/2001 | CN1279940A Beautifying wet coating face mask capable of curing acne and seborrheic diseases |
| 01/17/2001 | CN1279939A Local use cosmetic compositions containing benzaldoximes compounds |
| 01/17/2001 | CN1060678C Medicine for treatment of wart and its compounding method |
| 01/17/2001 | CN1060672C Congelation treating suspension |
| 01/17/2001 | CN1060671C Medicine for removing carbuncle and eliminating sore |
| 01/17/2001 | CN1060658C Pure Chinese herbal medicine film liquid for burn and its producing process |
| 01/17/2001 | CN1060649C Medicine for curing vitiligo |
| 01/16/2001 | US6175021 Human non-pancreatic secretory phospholipase a2 (spla2); inhibits release of arachidonic acid to treat septic shock; ((3-(2-amino-1,2-dioxoethyl)-2-methyl-1-(phenylmethyl)-1h-indol-4 -yl)oxylacetic acid, for example |
| 01/16/2001 | US6174993 Short peptides which selectively modulate the activity of serine/threonine kinases |
| 01/16/2001 | US6174895 1-aryl-3-arylmethyl-1,8-naphthyridin-4(1H)-ones |
| 01/16/2001 | US6174891 Antipruritic agent |
| 01/16/2001 | US6174889 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 01/16/2001 | US6174676 Cytokine-stress- and oncoprotein-activated human protein kinase kinases |
| 01/16/2001 | US6174534 Mixture containing fatty acid, ester of polyalkylene ether, hydrogenated palm oil and polyoxyethylenated hydrogenated palm kernel oil, fatty ester, glycerol, fatty alcohol and water |
| 01/16/2001 | US6174518 Photoprotective/cosmetic compositions comprising w/o/w stable triple emulsions |
| 01/16/2001 | CA2314539A1 Use of 4,6-dimethoxy-indole 2-carboxylic acid or its derivatives for the treatment of seborrhoea |
| 01/16/2001 | CA2188793C Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof |
| 01/11/2001 | WO2001002569A2 Human immune response molecules |
| 01/11/2001 | WO2001002567A1 16405 receptor, a g-protein coupled receptor |
| 01/11/2001 | WO2001002422A1 PROCESS FOR OBTAINING 17β-(N-TERC-BUTYLCARBAMOYL)-3-ONE-4-AZA-STEROIDS |
| 01/11/2001 | WO2001002406A1 Potassium channel blocking agents |
| 01/11/2001 | WO2001002398A1 Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them |
| 01/11/2001 | WO2001002388A1 Indole derivatives and their use for the treatment of osteoporosis amongst other applications |
| 01/11/2001 | WO2001002387A1 N-imidazolylmethyl carboxamides as nitric oxide production inhibitors |
| 01/11/2001 | WO2001002381A1 Piperazine derivatives as modulators of chemokine receptor activity |
| 01/11/2001 | WO2001002369A2 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| 01/11/2001 | WO2001002003A1 Method of treating psoriasis with il-15 antagonist |
| 01/11/2001 | WO2001001988A1 Compounds having cytokine inhibitory activity |
| 01/11/2001 | WO2001001970A2 New uses potassium channel openers, such as the treatment of epilepsy |
| 01/11/2001 | WO2001001963A1 A method for the improvement of transport across adaptable semi-permeable barriers |
| 01/11/2001 | WO2001001962A1 A method for the improvement of transport across adaptable semi-permeable barriers |
| 01/11/2001 | WO2001001947A1 Cosmetic skin care compositions containing cumic alcohol |
| 01/11/2001 | WO2001001932A2 Oligosaccharide aldonic acids and their topical use |
| 01/11/2001 | WO2001001923A2 Composition based on fluorinated polymer and alpha-hydroxy-acid salt for topical use for skin protection |
| 01/11/2001 | WO2001001748A2 Peptide compounds that bind her2 |
| 01/11/2001 | WO2000061608A3 Low-molecular inhibitors of complement proteases |
| 01/11/2001 | WO2000059904A3 Compounds and methods to treat cardiac failure and other disorders |
| 01/11/2001 | WO2000058466A3 Protease resistant flint analogs |
| 01/11/2001 | WO2000057840A3 Dermatological topical composition |
| 01/11/2001 | WO2000056345A3 Methods for limiting scar and adhesion formation |
| 01/11/2001 | WO2000054729A3 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 01/11/2001 | WO2000048581A3 Use of 5-ht3 receptor antagonists for treating musculoeskeletal diseases |
| 01/11/2001 | DE19932315A1 Benzoylpyridazine Benzoylpyridazine |
| 01/11/2001 | CA2378116A1 Human immune response molecules |
| 01/11/2001 | CA2376657A1 Indole derivatives and their use for the treatment of osteoporosis amongst other applications |
| 01/11/2001 | CA2375157A1 A method for the improvement of transport across adaptable semi-permeable barriers |
| 01/11/2001 | CA2373882A1 Compounds having cytokine inhibitory activity |
| 01/11/2001 | CA2373844A1 Cosmetic skin care compositions containing cumic alcohol |
| 01/11/2001 | CA2342864A1 Process for obtaining 17.beta.-(n-terc-butylcarbamoyl)-3-one-4-aza-steroids |
| 01/10/2001 | EP1067136A1 New peptide derivatives |
| 01/10/2001 | EP1066822A1 Composition for treating dandruffs in hair and scalp based on an antidandruff agent and a hydroxy-acid |
| 01/10/2001 | EP1066821A1 Topical cosmetic product containing benzaldoxims |
| 01/10/2001 | EP1066816A1 Agents promoting laminin production in skin cells |
| 01/10/2001 | EP1066378A2 Lyst protein complexes and lyst interacting proteins |
| 01/10/2001 | EP1066377A1 Methods for prevention and treatment of cancer |
| 01/10/2001 | EP1066316A1 Cinnamic acid derivatives having cell adhesion modulating activity |
| 01/10/2001 | EP1066290A1 PYRROLO[1,2-a]PYRAZINE sPLA 2 INHIBITOR |
| 01/10/2001 | EP1066286A1 Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors |
| 01/10/2001 | EP1066284A1 Benzo c]quinolizine derivatives and their use as 5 alpha-reductases inhibitors |
| 01/10/2001 | EP1066257A2 Heterocylic classes of compounds for the modulating tyrosine protein kinase |
| 01/10/2001 | EP1066061A1 Use of scatter factor to enhance angiogenesis |
| 01/10/2001 | EP1066051A1 Sciellin and uses thereof |
| 01/10/2001 | EP1066043A2 Materials and methods relating to the treatment of conditions involving mast cells, basophils and eosinophils |
| 01/10/2001 | EP1066025A1 Polyalkoxy copolymers as lipase inhibitors and their compositions |
| 01/10/2001 | EP1066017A1 Use of retinoic acid activity inhibitors to slow down hair loss |
| 01/10/2001 | EP1066015A1 Topical liquid composition for promoting hair growth and process of manufacturing thereof |
| 01/10/2001 | EP0944310A4 Stabilized ascorbyl compositions |
| 01/10/2001 | CN1279681A Piperidylaminomethyltrifluoromethyl cyclic ether compound as p substance antagonist |
| 01/10/2001 | CN1279676A Pseudopolymorphic forms of z-[2-[4-(bis(4-fluorophenyl)methyl]-1-piperazinyl]ethozy] acetic and dihydrochloride |
| 01/10/2001 | CN1279612A Modulation of immune responses |
| 01/10/2001 | CN1279603A Personal cleansing compositions comprising mid-chain branched surfactants |
| 01/10/2001 | CN1279078A Medicine for treating psoriasis and its preparing process |
| 01/10/2001 | CN1279060A Anhidrotic emulsion containing fine aluminum and zirconium powders, and preparing method thereof |
| 01/10/2001 | CN1060392C Medicine for curing recurrent stomatocace and Behcet's syndrome |
| 01/10/2001 | CN1060389C Chinese medicines for burns and scalds and preparation thereof |
| 01/10/2001 | CN1060380C Medicine for treating and healing wound |
| 01/10/2001 | CN1060379C Chinese medicine for treating vitiligo and preparation method thereof |
| 01/10/2001 | CN1060376C Chinese medicine preparation for skin diseases |
| 01/10/2001 | CN1060375C Traditional Chinese medicinal preparation for curing psoriasis |
| 01/10/2001 | CN1060365C New-medicine for curing burn, traumatism and preparation method thereof |
| 01/10/2001 | CN1060361C Chinese drug for curing burn and scald |
| 01/10/2001 | CN1060349C Capsule for regulating menstruation and eliminating chloasma and preparing method |
| 01/09/2001 | US6172250 Hydrolysis of an organosilicon compounds |
| 01/09/2001 | US6172096 Administering 4-pyrazolylbenzenesulfonamide derivatives to treat autoimmune diseases |
| 01/09/2001 | US6172080 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| 01/09/2001 | US6172074 Imidazopyridines and oxazolopyridines |